#United States #Indianapolis #Eli Lilly #Health Care #Goldman Sachs Conference

Eli Lilly at the Goldman Sachs Annual Global Health Care Conference

Eli Lilly and Company (NYSE: LLY) is poised to make an impactful appearance at the Goldman Sachs 46th Annual Global Health Care Conference scheduled for June 10, 2025, in New York City. This event is a significant gathering for leaders and innovators in the health care sector, and Eli Lilly's participation underscores its commitment to advancing health care solutions globally.

Lilly’s Contributions to Global Health
As a pioneer in the biopharmaceutical industry for nearly 150 years, Eli Lilly has continually focused on transforming health through innovation. The company is dedicated to solving complex health challenges, particularly in areas such as diabetes care, obesity treatment, Alzheimer’s disease, immune system disorders, and certain types of cancer.

Fireside Chat Details
The highlight of Lilly's participation will be a fireside chat featuring Lucas Montarce, the Executive Vice President and Chief Financial Officer of Lilly. This session will take place at 8 a.m. Eastern Time. Investors, analysts, and members of the public will have the opportunity to follow the discussion through a live audio webcast available on Lilly’s investor relations website (lilly.com/investor). After the live event, a replay will be made accessible for approximately 90 days, ensuring that those who cannot attend live still have access to the insights shared during the talk.

Lilly’s Mission and Values
Eli Lilly’s mission goes beyond business performance; it aims to improve the quality of life for millions of people around the world. Their scientists leverage biotechnology, chemistry, and genetic medicine to pioneer solutions for significant health challenges. The company emphasizes the importance of inclusivity in clinical trials, ensuring that diverse populations are represented in their studies and addressing accessibility and affordability in medicine.

Commitment to Accessibility
Lilly endeavors to ensure that its medicines are not only effective but also accessible to those who need them. This involves innovative approaches to research and patient care, seeking to provide affordable treatment options and reflecting a commitment to health equity across various demographics.

Conclusion
The upcoming Goldman Sachs 46th Annual Global Health Care Conference represents a pivotal moment for Eli Lilly to showcase its innovations and future directions in health care. With the invaluable insights from its leadership and a strong focus on addressing critical health issues, Lilly continues to be a key player in the global health landscape. Its participation promises to deepen the conversation around health care advancements and access, reaffirming Eli Lilly's role in shaping the future of medicine.

Stay tuned for updates from the conference and insights shared by Lilly's representatives. For more information on their latest developments, visit lilly.com and follow them on social media platforms such as Facebook and Instagram to stay connected with their progress in health care.